Inlybest — Axitinib 5 mg

Indicated for the treatment of Advanced Renal Cell Carcinoma (RCC).

It is used as a second-line therapy after failure of one prior systemic therapy (such as Sunitinib or cytokines).

• Uncontrolled Hypertension: Dangerously high blood pressure.
• Severe hepatic impairment (Child-Pugh Class C).
• Recent history of arterial thromboembolic events (stroke, heart attack) or severe bleeding within the last 12 months.
• Pregnancy and breastfeeding.

• Uncontrolled Hypertension: Dangerously high blood pressure.
• Severe hepatic impairment (Child-Pugh Class C).
• Recent history of arterial thromboembolic events (stroke, heart attack) or severe bleeding within the last 12 months.
• Pregnancy and breastfeeding.

The most common side effect is Hypertension (High Blood Pressure). Daily monitoring is required.

Other common reactions:

• Diarrhea: Stay hydrated and use anti-diarrheal meds if needed.
• Hand-Foot Syndrome: Redness, swelling, or pain on the palms of hands and soles of feet.
• Fatigue: Feeling weak or tired.
• Dysphonia: Hoarseness of voice.